shortage Mr Picard explained<\/a>: \u201cThe supply chain is complicated and aspirin manufacturers are not solely UK companies. they are European-wide companies and they manufacture for a number of countries. In the UK we have some of the cheapest generic prices in Europe and the government is trying to prevent spending too much on drugs and therefore as the number of prescriptions increases the price has to come down.<\/p>\n“What that has done is put pressure on the manufacturers to produce their drugs cheaper and cheaper and it has come to a point where the manufacturers are now saying the UK marked doesn\u2019t give us a good enough return and therefore we\u2019re no longer going to import our drugs into the UK and instead concentrating on other EU markets such as Germany, France or Italy which are paying a lot more for the aspirin.<\/p>\n
\u201cUnfortunately today we have a list of over 250 items, of course aspirin is on that list, there are some blood pressure medication and also antidepressants. Lots of medications that are affected and the list is growing simply because the prices that we are offering manufactueres in this country have come to be slow low that the manufacturers are pulling out of the UK market. It\u2019s as simple as that.\u201d<\/p>\n
He said one temporary solution was to give pharmacies the power to change prescriptions and that anyone impacted should go back to their doctor to ask to be prescribed an alternative. In a question to the Health Department Tory Mark Pritchard asked Secretary of State for Health and Social Care Wes Streeting: \u201cWhat steps he is taking to (a) increase the availability of aspirin and (b) normalise aspirin supply chains.\u201d<\/p>\n
Dr Zubir Ahmed, Parliamentary Under-Secretary (Department of Health and Social Care), said: \u201cThe Department is aware of a recent disruption to the supply of aspirin dispersible tablets and are working with suppliers to understand the causes and aid a return to normal supply as soon as possible. Supply issues have been addressed, and stock is regularly being made available for pharmacies to order.<\/p>\n
\u201cWe are working with all partners in the supply chain, including manufacturers and United Kingdom distributors, to ensure maximum accessibility to pharmacies and hospitals irrespective of where they are in the country. The Department will continue to monitor the situation and expects supplies to return to normal over the coming weeks.\u201d<\/p>\n
Ensure our latest headlines always appear at the top of your Google Search by making us a Preferred Source. <\/strong>Click here to activate<\/a><\/strong> or add us as your Preferred Source in your Google search settings.<\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"The government put aspirin on its export ban list to protect UK supplies and pharmacies around the country…\n","protected":false},"author":3,"featured_media":631984,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[34],"tags":[269573,1230,210,15072,1060,269575,565,108969,269574,67,132,68],"class_list":["post-631983","post","type-post","status-publish","format-standard","has-post-thumbnail","category-medication","tag-aspirin-shortage","tag-drugs","tag-health","tag-health-section","tag-medication","tag-national-pharmacy-association","tag-nhs","tag-supply-chain-issues","tag-uk-export-ban","tag-united-states","tag-unitedstates","tag-us"],"share_on_mastodon":{"url":"","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/631983","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/comments?post=631983"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/631983\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media\/631984"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media?parent=631983"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/categories?post=631983"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/tags?post=631983"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}